about RPO Clinical
RPO Clinical is a theranostic CRO located in the heart of Western Europe, the global epicentre of radiomolecular expertise. As a small, cross-functional team, we listen first, ask the right questions, and adapt accordingly, making for a flexible, tailor-made approach.
Prof Dr Richard P Baum (MD PhD), Chairman, is the current Chairman of the Advanced Theranostic Centre for Radiomolecular Precision Oncology at CURANOSTICUM (Wiesbaden-Frankfurt, Germany), President of the Academy (International Centers for Precision Oncology (ICPO)), and Professor of Nuclear Medicine (University of Frankfurt-Main, Germany). Within RPO Clinical, he is the clinical and medical opinion leader, offering advice and consultancy on study strategy and design.connect on LinkedIn
Dr Hugo M L Jansen (PharmD MD PhD), CMO, is a clinical pharmacologist and nuclear radiologist. Within RPO Clinical, he now will act as business, imaging, medical and science liaison. With nearly 30 years of life science and clinical experience, Dr Jansen has an extensive background working with hospitals and companies focused on theranostics.connect on LinkedIn
Christina King (MSc human biology), COO, has over 20 years experience in global clinical development with an emphasis on cancer drugs both in biotech and big pharma, as well as in large CROs and niche service providers. Within RPO Christina will oversee the set-up and execution of all clinical studies, and serve as a liaison for our clients.connect on LinkedIn
Chloé Raman (MD accounting & finance), finance and administration manager, has over 15 years experience in financial strategy, budgeting & planning, capital structure guidance, financial IT, legal, and human resources, both in large and small private & public companies. Within RPO, Chloé now will support management in setting the strategic plan for growth and business objectives and lead the annual budgeting and planning process. She will provide oversight and management of the financial and administrative status.connect on LinkedIn
Rikki N Waterhouse (BA PhD radiochemistry), Senior Director Imaging and Biomarker Development, has over 25 years experience in novel radiopharmaceuticals and biomarkers for drug development in therapeutic applications. She has worked in academic and pharmaceutical settings, is experienced in medical and regulatory writing (USA), and managing projects in the (non)clinical space.connect on LinkedIn
ask me anything
RPO Clinical offers a free 'Ask-Me-Anything' session.
Please fill in the form below:
We will get back to you as soon as possible.